Related Experiment Video
Updated: Dec 14, 2025
07:29
Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
9.6K
Preβ1-High-Density Lipoprotein in Cardiovascular Diseases
1Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai, China. medlipo@126.com.
Advances in Experimental Medicine and Biology
|July 25, 2020
Summary
Lower levels of serum prebeta1-high-density lipoprotein (preβ1-HDL) predict more severe coronary artery stenosis. This study introduces a new method for quantifying preβ1-HDL to better understand its role in coronary artery disease.
Area of Science:
- Cardiovascular Medicine
- Lipoprotein Metabolism
- Biochemistry
Background:
- Serum prebeta1-high-density lipoprotein (preβ1-HDL) is a lipoprotein fraction with debated quantification methods.
- Its association with coronary artery disease (CAD) requires further clarification.
- Traditional methods like 2D gel electrophoresis have limitations.
Purpose of the Study:
- To establish a novel and simple method for quantifying human serum preβ1-HDL.
- To investigate the relevance of preβ1-HDL levels in predicting coronary artery stenosis severity.
Main Methods:
- Development of a new, simple assay for preβ1-HDL quantification.
- Utilizing the new method to analyze serum samples.
- Correlating preβ1-HDL levels with coronary artery stenosis severity.
Main Results:
- A novel, simple method for quantifying preβ1-HDL was successfully established.
- Lower serum preβ1-HDL levels were identified as an independent predictor of more severe coronary artery stenosis.
- The findings highlight a significant association between preβ1-HDL and CAD.
Conclusions:
- The developed method offers a straightforward approach for preβ1-HDL quantification.
- Reduced preβ1-HDL is a significant independent predictor of coronary artery stenosis.
- Further research into preβ1-HDL's role in cardiovascular disease is warranted.
Related Concept Videos
01:26Coronary Artery Disease IV: Preventive Measures
513
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
513
01:25Blood Studies for Cardiovascular System III: Serum Lipid Profile
478
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
478
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
412
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
412
01:30Coronary Artery Disease I: Introduction
748
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
748
01:30Atherosclerosis I: Introduction
596
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
596
01:26Coronary Artery Disease II: Pathophysiology
261
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
261